Nexalin Technology, Inc. (NXL)
NCM · Healthcare · Medical Devices
Closing price as of 2026-07-29 · Source: TEK2day Finance
Key Metrics
About Nexalin Technology, Inc.
Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health epidemic in the United States and China. The company offers Generation 1, an easy-to-administer medical device which utilizes bioelectronic medical technology to treat anxiety, insomnia, and depression without the need for drugs or psychotherapy; and Generation 2 and Generation 3 headset devices for the treatment of depression, substance use disorder, traumatic brain injury, post-traumatic stress disorder, opioid addiction, alcoholism, and chronic pain, as well as alzheimer's disease, and dementia. Nexalin Technology, Inc. is headquartered in Houston, Texas.
Quarterly Financials
| Metric | 2025-06-30 | 2025-09-30 | 2025-12-31 | 2026-03-31 |
|---|---|---|---|---|
| Revenue | 71K | 18K | 172K | 15K |
| Gross Profit | 48K | 14K | 151K | 13K |
| Operating Income | -1.6M | -2.3M | -2.4M | -2.1M |
| Net Income | -1.6M | -2.3M | -2.4M | -2.1M |
| Diluted EPS | $-0.10 | $-0.13 | $nan | $-0.11 |
Annual Financials
| Metric | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Revenue | 1.3M | 111K | 169K | 302K |
| Gross Profit | 958K | 85K | 132K | 240K |
| Operating Income | -1.8M | -5.7M | -7.8M | -8.4M |
| Net Income | -1.7M | -4.6M | -7.6M | -8.2M |
| Diluted EPS | $-0.30 | $-0.63 | $-0.83 | $-0.50 |